Skip to content
AnalystLens

James Hardie Industries 8-K Report (Oct 2, 2025)

Filing Date
Filed October 2, 2025
Period End
October 2, 2025
Securities
JHXJHIUF
In the record · 2016–202610-K1210-Q28-K402

JHX filed 12 annual reports (10-K), 2 quarterly reports (10-Q) and 402 current reports (8-K) between 2016 and 2026.

  1. Leadership change8-K · Oct ’26Oct ’26

Summary

Summary of the 6-K filed October 2, 2025. Cited figures are marked; the original filing is the authoritative source.

James Hardie Industries plc (ASX/NYSE: JHX) filed a set of exhibits on October 2, 2025, consisting of three substantial shareholding notices and a supplementary presentation on executive compensation.

The shareholding notices show State Street Corporation and its affiliates reporting holdings of 2.86%a (notified September 25, 2025) and 2.88% (notified September 26, 2025), both down from 3.88% in prior notifications. FMR LLC reported a resulting holding of 2.9928% of voting rights, down from 3.9444%, as of September 26, 2025, against a total of 579,185,043 voting rights in the issuer. The compensation presentation, dated October 1, 2025, reports FY25 incentive outcomes.

The short-term corporate payout was 1.5x target, and the long-term incentive payouts were no payout for rTSR, 2.0x target for ROCE (based on 48.6% ROCE), and 1.57x target for the Scorecard. The filing states FY25 realizable CEO pay of $7.7Mb against FY25 target pay of $8.6M, a decline of more than 10%. For FY26, the Board raised the weighting of ROCE and relative TSR to 33% each, reduced the Scorecard weighting from 50% to 33%, lowered the maximum LTI payout from 250% to 233%, and changed the rTSR peer group to the S&P 500 Index.

FY26 CEO target compensation was left unchanged. The presentation links the FY26–28 ROCE targets to the AZEK acquisition, which the filing says has a short-term downward impact on ROCE. The Scorecard includes North America integration targets of $125Mc in cost synergies and $113M in commercial synergies.

The filing states that achieving the North America threshold metrics would result in $5.8Bd+ of company net sales and $1.5B+ of EBITDA in FY28. The filing also notes that 80% of James Hardie revenue comes from the U.S.

Key Highlights

  1. Substantial holdings notices show State Street reporting 2.86% (notified September 25, 2025) and 2.88% (notified September 26, 2025), both down from 3.88%.
  2. FMR LLC reported a resulting holding of 2.9928% of voting rights as of September 26, 2025, down from 3.9444%, against 579,185,043 total voting rights.
  3. FY25 short-term corporate incentive paid at 1.5x target, citing strong financial performance and record APAC EBIT margin and record Europe net sales.
  4. FY25 LTI outcomes: no payout for rTSR, 2.0x target for ROCE (48.6% ROCE), and 1.57x target for the Scorecard.
  5. FY25 realizable CEO pay of $7.7M versus $8.6M FY25 target pay, a decline of more than 10%.
  6. FY26 LTI redesign: ROCE and rTSR each raised to 33% weighting, Scorecard reduced from 50% to 33%, maximum LTI payout lowered from 250% to 233%, and rTSR peer group changed to the S&P 500 Index.
  7. FY26–28 ROCE targets reflect the AZEK acquisition's short-term downward impact on ROCE, with ROCE expected to improve annually after FY26.

Frequently Asked Questions

  1. Why did the reported holdings from State Street and FMR change in late September 2025?

    The filing does not explain the reasons for the changes. It reports that State Street's holding fell from 3.88% to 2.86% (notified September 25, 2025) and to 2.88% (notified September 26, 2025), and that FMR LLC's holding fell from 3.9444% to 2.9928% as of September 26, 2025. FMR's notice states the reason as a stock merger after M&A completion.

  2. How did executive incentive payouts compare with performance for FY25?

    The filing reports a 1.5x target payout for the short-term corporate incentive, reflecting strong financial performance. Long-term payouts were 2.0x target for ROCE, based on 48.6% ROCE, 1.57x target for the Scorecard, and no payout for relative TSR, which was below threshold. The Board also applied negative discretion to the short-term payout to uphold its Zero Harm standard.

  3. What changed in the FY26 long-term incentive plan?

    The filing says the changes reflect shareholder feedback. ROCE and relative TSR weightings each rose to 33%, the Scorecard weighting fell from 50% to 33%, the maximum LTI payout dropped from 250% to 233%, and the rTSR peer group changed to the S&P 500 Index. The Scorecard now assigns explicit metric weights and pays nothing for below-target results. FY26 CEO target pay was unchanged.

  4. How does the AZEK acquisition affect the compensation targets?

    The filing states that the AZEK acquisition has a short-term downward impact on ROCE, because acquisition costs such as the step-up of AZEK's PP&E are recorded upfront while synergies come later. The FY26–28 ROCE targets, which pay from 0.0x below 25.0% ROCE up to 2.0x above 35.0%, are based on a preliminary pro-forma estimate for the combined company.